NAMPT and cancer: NAMPT overexpression is observed in various cancers, with certain types relying on NAMPT for NAD+ biosynthesis, making it a promising target for developing future anticancer inhibitors [for recent reviews, see Wei et al. (57), Wen et al. (15), and Velma et al. (40)].